You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cohort expansion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Singapore (YS-0N-001)

Recruiting
  • Cancer
  • YS-0N-001
  • Singapore, Singapore
    National University Cancer Institute Singapore
Dec 20, 2022

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Solid Tumor Trial (ZGGS18 for Injection)

Not yet recruiting
  • Solid Tumor
  • ZGGS18 for Injection
  • (no location specified)
Oct 13, 2022

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Advanced Solid Tumor, Advanced Lung Cancer, Advanced Gastric Carcinoma Trial in Beijing, Shanghai (IMM2902)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Beijing, China
  • +1 more
Apr 6, 2023

Advanced Solid Tumors Trial in China (IMM2510)

Recruiting
  • Advanced Solid Tumors
  • Luoyang, Henan, China
  • +3 more
Jul 25, 2023

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • LB2102
  • (no location specified)
Jan 10, 2023

Advanced Solid Tumor or Lymphoma Trial in United States (BJ-005)

Recruiting
  • Advanced Solid Tumor or Lymphoma
  • BJ-005
  • Phoenix, Arizona
  • +5 more
Jul 19, 2022

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Solid Tumor Trial (BB-1705)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
May 16, 2022

Oncology Trial in Australia (IMM47)

Not yet recruiting
  • Oncology
  • Sydney, New South Wales, Australia
  • +3 more
Aug 8, 2023

Solid Tumors, Tumors, Malignant Tumor Trial in Changchun (ES102)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Oct 19, 2022

Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

Recruiting
  • Neoplasms
  • Brno, Czechia
  • +20 more
Nov 21, 2022

Solid Tumor, Adult Trial in Australia (IOS-1002, IOS-1002 + PD-1 mAb)

Recruiting
  • Solid Tumor, Adult
  • Clayton, Australia
  • +4 more
Mar 15, 2023

Advanced Solid Tumor Trial in Gold Coast, Adelaide, Melbourne (MHB036C)

Not yet recruiting
  • Advanced Solid Tumor
  • Gold Coast, Queensland, Australia
  • +2 more
Jan 5, 2023

Metastatic Colorectal Cancer Trial (AUM001, Pembrolizumab, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Jul 13, 2022

Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • CTX131
  • Nashville, Tennessee
    Research Site 1
Mar 21, 2023

Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer Trial in New Taipei City, Taipei

Completed
Has Results
  • Metastatic Gastric Cancer
  • +3 more
  • New Taipei City, Taiwan
  • +3 more
Sep 21, 2022

Advanced Solid Tumor Trial in Zhengzhou (BAT1308)

Recruiting
  • Advanced Solid Tumor
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Dec 15, 2021

Melanoma Trial in Houston (APX005M, Pembrolizumab)

Recruiting
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)

Active, not recruiting
  • Advanced Solid Tumors
  • Macquarie, New South Wales, Australia
  • +6 more
Dec 1, 2022

Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

Not yet recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Jun 23, 2022

Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) Trial (DB-OTO)

Not yet recruiting
  • Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
  • DB-OTO
  • (no location specified)
Mar 28, 2023